Special: This May Soon Be the Most Talked-About $3 Stock in America

  • Facebook
  • Twitter
  • Podcast
  • Twitter
  • Facebook
mobile-logo
Top

Debit spread

0
0
Debit spread

News can create large moves in biotechs. This was recently the case, as Benzinga reported, for Sarepta Therapeutics Inc (Nasdaq: SRPT). The news site reported, “the FDA has granted accelerated approval for its Vyondys 53, aka golodirsen — an antisense oligonucleotide — for the treatment of Duchenne muscular dystrophy,...

by

Share
« Previous PageNext Page »
LEGAL DISCLAIMER

Never invest in a security or idea featured on our site or in our emails unless you can afford to lose your entire investment. We are not registered investment advisors or brokers/dealers and we do not purport to be. Furthermore, the investment ideas and opinions expressed on OptionsProfitsDaily.com and in our Options Profits Daily newsletter are NOT specific buy and sell recommendations customized for you, an individual. The ideas we feature should simply serve as a starting point for further research and due diligence on your part. Actual buy and sell decisions for your own portfolio are entirely up to you. We make no representations, warranties or guarantees as to the accuracy or completeness of the content featured on our site or in our emails. Furthermore, the article authors and contributors may own securities mentioned in their articles and not disclose this information. By using OptionsProfitsDaily.com or reading our Options Profits Daily newsletter you agree to our Terms & Conditions, Disclaimer and Privacy Policy.

SIGN UP

Click here for Advertising Inquires

FacebookTwitterPodcast

Copyright [email protected] Options Profits Daily. All Rights Reserved.

Updated Terms

We've revised our Terms of Service, Privacy Policy, and Cookie Policy By accepting you agree to our updated terms and policies, Please take a few minutes to read and understand them.
Accept